A Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy.
The first cases of early-onset progressive polyneuropathy appeared in the Alaskan Malamute population in Norway in the late 1970s. Affected dogs were of both sexes and were ambulatory paraparetic, progressing to non-ambulatory tetraparesis. On neurologic examination, affected dogs displayed predomin...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/8455050285dc4931a8f4584a8dc8e995 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:8455050285dc4931a8f4584a8dc8e995 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:8455050285dc4931a8f4584a8dc8e9952021-11-18T07:58:50ZA Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy.1932-620310.1371/journal.pone.0054547https://doaj.org/article/8455050285dc4931a8f4584a8dc8e9952013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23393557/?tool=EBIhttps://doaj.org/toc/1932-6203The first cases of early-onset progressive polyneuropathy appeared in the Alaskan Malamute population in Norway in the late 1970s. Affected dogs were of both sexes and were ambulatory paraparetic, progressing to non-ambulatory tetraparesis. On neurologic examination, affected dogs displayed predominantly laryngeal paresis, decreased postural reactions, decreased spinal reflexes and muscle atrophy. The disease was considered eradicated through breeding programmes but recently new cases have occurred in the Nordic countries and the USA. The N-myc downstream-regulated gene (NDRG1) is implicated in neuropathies with comparable symptoms or clinical signs both in humans and in Greyhound dogs. This gene was therefore considered a candidate gene for the polyneuropathy in Alaskan Malamutes. The coding sequence of the NDRG1 gene derived from one healthy and one affected Alaskan Malamute revealed a non-synonymous G>T mutation in exon 4 in the affected dog that causes a Gly98Val amino acid substitution. This substitution was categorized to be "probably damaging" to the protein function by PolyPhen2 (score: 1.000). Subsequently, 102 Alaskan Malamutes from the Nordic countries and the USA known to be either affected (n = 22), obligate carriers (n = 7) or healthy (n = 73) were genotyped for the SNP using TaqMan. All affected dogs had the T/T genotype, the obligate carriers had the G/T genotype and the healthy dogs had the G/G genotype except for 13 who had the G/T genotype. A protein alignment showed that residue 98 is conserved in mammals and also that the entire NDRG1 protein is highly conserved (94.7%) in mammals. We conclude that the G>T substitution is most likely the mutation that causes polyneuropathy in Alaskan Malamutes. Our characterization of a novel candidate causative mutation for polyneuropathy offers a new canine model that can provide further insight into pathobiology and therapy of human polyneuropathy. Furthermore, selection against this mutation can now be used to eliminate the disease in Alaskan Malamutes.Camilla S BruunKarin H JäderlundMette BerendtKristine B JensenEva H SpodsbergHanne GredalG Diane SheltonJames R MickelsonKatie M MinorHannes LohiInge BjerkåsOyvind StigenArild EspenesCecilia RohdinRebecca EdlundJennie OhlssonSigitas CizinauskasPáll S LeifssonCord DrögemüllerLars MoeSusanna CireraMerete FredholmPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 2, p e54547 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Camilla S Bruun Karin H Jäderlund Mette Berendt Kristine B Jensen Eva H Spodsberg Hanne Gredal G Diane Shelton James R Mickelson Katie M Minor Hannes Lohi Inge Bjerkås Oyvind Stigen Arild Espenes Cecilia Rohdin Rebecca Edlund Jennie Ohlsson Sigitas Cizinauskas Páll S Leifsson Cord Drögemüller Lars Moe Susanna Cirera Merete Fredholm A Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy. |
| description |
The first cases of early-onset progressive polyneuropathy appeared in the Alaskan Malamute population in Norway in the late 1970s. Affected dogs were of both sexes and were ambulatory paraparetic, progressing to non-ambulatory tetraparesis. On neurologic examination, affected dogs displayed predominantly laryngeal paresis, decreased postural reactions, decreased spinal reflexes and muscle atrophy. The disease was considered eradicated through breeding programmes but recently new cases have occurred in the Nordic countries and the USA. The N-myc downstream-regulated gene (NDRG1) is implicated in neuropathies with comparable symptoms or clinical signs both in humans and in Greyhound dogs. This gene was therefore considered a candidate gene for the polyneuropathy in Alaskan Malamutes. The coding sequence of the NDRG1 gene derived from one healthy and one affected Alaskan Malamute revealed a non-synonymous G>T mutation in exon 4 in the affected dog that causes a Gly98Val amino acid substitution. This substitution was categorized to be "probably damaging" to the protein function by PolyPhen2 (score: 1.000). Subsequently, 102 Alaskan Malamutes from the Nordic countries and the USA known to be either affected (n = 22), obligate carriers (n = 7) or healthy (n = 73) were genotyped for the SNP using TaqMan. All affected dogs had the T/T genotype, the obligate carriers had the G/T genotype and the healthy dogs had the G/G genotype except for 13 who had the G/T genotype. A protein alignment showed that residue 98 is conserved in mammals and also that the entire NDRG1 protein is highly conserved (94.7%) in mammals. We conclude that the G>T substitution is most likely the mutation that causes polyneuropathy in Alaskan Malamutes. Our characterization of a novel candidate causative mutation for polyneuropathy offers a new canine model that can provide further insight into pathobiology and therapy of human polyneuropathy. Furthermore, selection against this mutation can now be used to eliminate the disease in Alaskan Malamutes. |
| format |
article |
| author |
Camilla S Bruun Karin H Jäderlund Mette Berendt Kristine B Jensen Eva H Spodsberg Hanne Gredal G Diane Shelton James R Mickelson Katie M Minor Hannes Lohi Inge Bjerkås Oyvind Stigen Arild Espenes Cecilia Rohdin Rebecca Edlund Jennie Ohlsson Sigitas Cizinauskas Páll S Leifsson Cord Drögemüller Lars Moe Susanna Cirera Merete Fredholm |
| author_facet |
Camilla S Bruun Karin H Jäderlund Mette Berendt Kristine B Jensen Eva H Spodsberg Hanne Gredal G Diane Shelton James R Mickelson Katie M Minor Hannes Lohi Inge Bjerkås Oyvind Stigen Arild Espenes Cecilia Rohdin Rebecca Edlund Jennie Ohlsson Sigitas Cizinauskas Páll S Leifsson Cord Drögemüller Lars Moe Susanna Cirera Merete Fredholm |
| author_sort |
Camilla S Bruun |
| title |
A Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy. |
| title_short |
A Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy. |
| title_full |
A Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy. |
| title_fullStr |
A Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy. |
| title_full_unstemmed |
A Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy. |
| title_sort |
gly98val mutation in the n-myc downstream regulated gene 1 (ndrg1) in alaskan malamutes with polyneuropathy. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/8455050285dc4931a8f4584a8dc8e995 |
| work_keys_str_mv |
AT camillasbruun agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT karinhjaderlund agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT metteberendt agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT kristinebjensen agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT evahspodsberg agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT hannegredal agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT gdianeshelton agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT jamesrmickelson agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT katiemminor agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT hanneslohi agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT ingebjerkas agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT oyvindstigen agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT arildespenes agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT ceciliarohdin agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT rebeccaedlund agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT jennieohlsson agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT sigitascizinauskas agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT pallsleifsson agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT corddrogemuller agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT larsmoe agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT susannacirera agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT meretefredholm agly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT camillasbruun gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT karinhjaderlund gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT metteberendt gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT kristinebjensen gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT evahspodsberg gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT hannegredal gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT gdianeshelton gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT jamesrmickelson gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT katiemminor gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT hanneslohi gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT ingebjerkas gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT oyvindstigen gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT arildespenes gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT ceciliarohdin gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT rebeccaedlund gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT jennieohlsson gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT sigitascizinauskas gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT pallsleifsson gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT corddrogemuller gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT larsmoe gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT susannacirera gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy AT meretefredholm gly98valmutationinthenmycdownstreamregulatedgene1ndrg1inalaskanmalamuteswithpolyneuropathy |
| _version_ |
1718422678392537088 |